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OBJECTIVE: To understand the relationships between brain structures and function (behavior and cognition) in
healthy aging.
METHOD: The study group was composed of 56 healthy elderly subjects who underwent neuropsychological
assessment and quantitative magnetic resonance imaging. Cluster analysis classified the cohort into two
groups, one (cluster 1) in which the magnetic resonance imaging metrics were more preserved (mean age: 66.4
years) and another (cluster 2) with less preserved markers of healthy brain tissue (mean age: 75.4 years).
RESULTS: The subjects in cluster 2 (older group) had worse indices of interference in the Stroop test compared
with the subjects in cluster 1 (younger group). Therefore, a simple test such as the Stroop test could
differentiate groups of younger and older subjects based on magnetic resonance imaging metrics.
CONCLUSION: These results are in agreement with the inhibitory control hypotheses regarding cognitive aging
and may also be important in the interpretation of studies with other clinical groups, such as patients with
dementia and mild cognitive impairment.
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& INTRODUCTION
The progressive degeneration of tissues, including brain
parenchyma, is an expected event of aging even under
normal physiological conditions. This fact has been docu-
mented not only in studies of brain volume, but also by
other neuroimaging modalities sensitive to myelin impair-
ment. Previous imaging reports showed volume decreases
and diffusion facilitation related to aging. The loss of white
matter (WM) integrity and gray matter (GM) volume is
found mostly in the frontal lobe (1-3). The hippocampus
also shows structural changes associated with aging, but
they are less severe than those found in Alzheimer’s disease
and are not associated with the involvement of the area
around the entorhinal cortex (1,4).
The prefrontal cortices, therefore, are most affected by
aging compared with other neocortical regions, followed by
volume loss in the temporal, parietal, and occipital lobes (5).
Little research exists regarding subcortical structures in
aging, but they appear to change little with aging.
Additionally, it appears that the greatest shrinkage across
the lifespan occurs mostly in the caudate and cerebellum (6).
Given this framework, age-related brain changes may be
expected to correlate with cognitive dysfunction, which can
be encountered in Alzheimer’s disease (AD). Positive
correlations have been found between AD and memory,
executive functions, and frontal and temporal regions,
whereas negative correlations have been described in
elderly controls between executive functions, memory
processes, and frontal regions (7). This result could be
explained by the continual loss of cortical thickness and
brain volume, including the "pruning" and neuronal
reorganization inherent in human development, which
results in the selection of the most capable neurons, leading
elderly people with smaller brain volumes to exhibit
performances that are higher than expected for their
normative group. Other authors have reviewed the research
in the past years and still encountered contradictory
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findings regarding the evidence that age-related changes in
the volume of specific brain structures have direct con-
sequences for cognitive function. Therefore, the relation-
ships between structure (brain) and function (behavior and
cognition) in healthy aging remain controversial.
Another area of interest is the age at which the greatest loss
in cognition occurs. There is no consensus regarding whether
it begins after age 70, after age 80, or even between these ages
(8-11). Because of this lack of consensus, another of our
objectives was to compare MRI markers of neuropsycholo-
gical performance in a group of younger healthy elderly (12)
with those in an older healthy elderly group (13) to
understand the differences between these groups.
Regarding brain structure, the MRI analysis included
volumetric quantitative techniques; relaxometry (quantita-
tive T2), which is a marker of the presence of changes in the
concentration of intra- and extracellular water in tissues;
and evaluation of the magnetization transfer ratio (MTR),
which is used to infer demyelination and axonal damage. In
the neuropsychological assessment, techniques and tests
that were sensitive to disorders associated with aging were
applied and were translated into Portuguese.
Therefore, the objective of this study was to compare
structural changes (both global and lobar gyri changes) on
MRI with patterns of functional performance on neuropsy-
chological tests to identify a connection between structure
and function in the spectrum of normal aging.
& PATIENTS AND METHODS
Study design
This was a prospective case-control study with normal
elderly subjects submitted to an extensive medical evalua-
tion to exclude both dementia and mild cognitive impair-
ment (MCI). Both subgroups were studied with an
extensive MRI protocol that included regular sequences
and quantitative measurements of the cortical surface
segmentation, brain parenchymal fraction (BPF), white
matter (WM) and gray matter (GM) volume, magnetiza-
tion transfer ratio (MTR), and quantitative T2 (qT2) of WM
and GM. We extracted the values from maps of each
group, and changes were evaluated based on these
physical characteristics. The patients, based on their MRI
characteristics, were divided into two subsets of indivi-
duals that exhibited higher (cluster 1) and lower (cluster 2)
performance.
Participants
The study group consisted of 56 elderly subjects, aged
58 to 83 years (mean¡SD: 68.2¡6.22 years), who had
completed 1 to 15 years of schooling (7.4¡4.37 years). All
subjects were diagnosed as healthy, with the exclusion of
any abnormality that may interfere with cognitive and
cerebral functioning. The study was approved by the
Research Ethics Committee, and all subjects provided
written informed consent to participate in the study.
Procedures
One expert geriatrician evaluated all participants to
exclude medical conditions that may interfere with
cognitive and cerebral functioning, such as diseases of
the central nervous system that compromised cognitive
function; sensorineural deficits (meaningful hearing loss,
visual or color recognition deficit) or sensorimotor
incapacitation that would impair the execution of the
proposed tests; psychiatric disorder; history of chronic
alcoholism (.3 drinks per day); clinical delirium; oxygen-
dependent pulmonary conditions (partial pressure of
oxygen less than 60 mmHg); pulmonary diseases or severe
refractory asthma; endocrine-metabolic and nutritional
conditions determined by laboratory tests, such as the
venereal disease research laboratory (VDRL), calcium,
fasting blood glucose, HMG, and TSH tests (i.e., diabetes
mellitus, hypo/hyperthyroidism, hypercalcemia, growth
hormone deficiency, conditions of hypo- or hypercortiso-
lism, vitamin B12 or folic acid and niacin deficiency, and
anemia with hemoglobin levels below 10 mg/dl); and
cardiovascular disorders, including a diagnosis of severe
or end-stage heart disease, a history of acute myocardial
infarction or documented coronary disease, moderate
to severe hypertension, and advanced atherosclerosis.
Additionally, participants taking any of the following
medications were also excluded: neuroleptics, tricyclic
antidepressants, anticonvulsants, methyldopa, clonidine or
similar drugs, corticoids (.5 mg of prednisone or equiva-
lent), and benzodiazepines (for less than 6 months or at a
dose of more than 10 mg of diazepam per day, or
equivalent).
The instruments used to test study-eligible patients
included the Brazilian version of the MINI International
Neuropsychiatric Interview, which is a short, structured
diagnostic interview used to diagnose psychiatric condi-
tions, such as mood disorders and psychosis (14), and the
Brazilian version of the Mini Mental State Exam (Folstein
et al., 1975), adopting the criteria of 2 standard deviations
above the mean for normal seniors with the same education
level of this study group for exclusion of the diagnosis of
dementia (3). The participants had to have scored 26-30
points on the Mini- Mental State Exam and passed the
screening procedure in the short structured diagnostic
interview (Mini International Neuropsychiatric Interview -
Brazilian version). In addition, the subjects underwent
activities of daily living assessment using the Katz scale,
which must show preserved indices (scores: 0), i.e.,
independent activities of daily living scale (15) and
Clinical Dementia Rating (CDR) scale, which includes
indices of 0 and 0.5 (16). After this screening procedure,
the participants proceeded to the MRI scan and neuropsy-
chological assessment.
MRI protocol
MRI images were acquired in a 1.5-Tesla MR machine
(Magnetom Vision; Siemens, Erlangen, Germany). The
image protocol included two identical axial gradient-echo
sequences (TR= 34 ms; TE= 11 ms; slice thickness = 5 mm;
and number of slices = 34), with and without a magnetiza-
tion transfer pulse, used to generate the MTR map; one
axial SE multi-echo sequence (TR= 3000 ms; TE=22/60/
120 ms; and 20 slices, 5-mm thickness), used to generate
the T2 relaxometry map; and one sagittal volumetric
3DT1 MPRAGE sequence (TR= 9.7 ms; TE= 4 ms, and
160 slices 1-mm thick), used for volumetry and tissue
classification.
MRI analysis
Segmentation of regions. The automated procedures for
obtaining volumetric measurements of the different brain
structures were described by Fischl et al. (17). This
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procedure was accomplished using the Freesurfer package
version 4.5 (Martinos Center for Biomedical Imaging,
Charlestown, Massachusetts, USA). This software classifies
each voxel with a neuroanatomical label based on
probabilistic information automatically estimated from
a manually labeled training set. Initially, an optimal linear
transform was computed to maximize the likelihood of
the input image based on an atlas constructed from
manually labeled images. Next, a nonlinear transform
was initialized with the transformation of the previous
step, and the image was deformed until a better match of
the atlas was obtained. Finally, a Bayesian segmentation
procedure was applied, and the maximum a posteriori
estimate of the labeling was computed. The technique has
been previously shown to be comparable in accuracy to
manual labeling (17). The Freesurfer system provides the
volumes of the classified structures and cortical thickness
values.
MTR map. The MTR map is a percent-difference image
calculated voxel-by-voxel from one pair of identical
sequences, except for the presence or absence of the MT
pulse, using the following formula (18):
MTR~
M0-MS
M0
|100 ð1Þ
where (MO) is the signal intensity of the pixel with no MT
pulse, Ms is the signal intensity of the pixel with the MT
pulse, and MTR is the magnetization transfer ratio. We used
the Mincmath tool (19) to construct the MTR map for each
exam.
Relaxometry map. A natural logarithm (ln) was applied
in the multi-echo images. A linear equation results from this
procedure:
ln S ~r,TEð Þ½ ~ ln S0 ~rð Þ½ { 1
T2 ~rð Þ|TE ð2Þ
where S ~r,TEð Þ and S0 ~rð Þ represent the pixel intensity at the
position ~r in the image obtained at the TE echo time and
‘‘ideal’’ 0 echo time, respectively. Therefore, a linear least
squares method can be used to estimate the T2 pixel value
(T2 ~rð Þ) from the obtained TE images. The in-house script
"Relaxon" was implemented for this purpose using MINC
tools.
Estimation of global measures and cluster analysis. After
the segmentation, the global measures were computed. The
following parameters were calculated:
Brain parenchyma fraction (%).
BPF~
WMVzGMVð Þ
ICV
|100 ð3Þ
where WMV is the white matter volume, GMV is the gray
matter volume, and ICV is the intracranial volume.
Percentage of white matter (%).
PWM~
LWMVCerebralzRWMVCerebralzLWMVCerebellumzRWMVCerebellumð Þ
ICV
|100 ð4Þ
where LWMV is the white matter volume of the left
hemisphere, RWMV is the white matter volume of the
right hemisphere, and ICV is the intracranial volume.
Percentage of gray matter (%).
PGM~
LGMVCerebralzRGMVCerebralzLGMVCerebellumzRGMVCerebellumð Þ
ICV
|100 ð5Þ
where LGMV is the gray matter volume of the left
hemisphere, RGMV is the gray matter volume of the right
hemisphere, and ICV is the intracranial volume.
MTR of white matter (%):
MTRWM~LMTRWMCerebralzRMTRWMCerebral
zLMTRWMCerebellumzRMTRWMCerebellum
ð6Þ
where LMTRWM is the white matter MTR of the left
hemisphere and RMTRWM is the white matter MTR of the
right hemisphere.
MTR of Gray matter (%):
MTRGM~LMTRGMCerebralzRMTRGMCerebral
zLMTRGMCerebellumzRMTRGMCerebellum
ð7Þ
where LMTRGM is the white matter MTR of the left
hemisphere and RMTRGM is the white matter MTR of the
right hemisphere.
Relaxometry of white matter (ms):
RXWM~LRXWMCerebralzRRXWMCerebral
zLRXWMCerebellumzRRXWMCerebellum
ð8Þ
where LRXWM is the white matter relaxometry of the left
hemisphere and RRXWM is the white matter relaxometry of
the right hemisphere.
Relaxometry of gray matter (ms):
RXGM~LRXGMCerebralzRRXGMCerebral
zLRXGMCerebellumzRRXGMCerebellum
ð9Þ
where LRXWM is the white matter relaxometry of the left
hemisphere and RRXWM is the white matter relaxometry of
the right hemisphere.
The patients, based on their MRI characteristics, were
divided using k-means cluster analyses implemented in
Minitab software, and two groups were formed: cluster 1,
which had the best results with respect to quantitative MRI
measures (high volumes and MTRs), and cluster 2, which
had the worst results (low volumes and MTR values and
high T2 values). The k-means cluster analysis is used to
cluster observations into groups when the groups are
initially unknown. This procedure uses non-hierarchical
clustering of observations.
Cluster analysis and comparison. Using the MTR,
relaxometry, volumes of cortical and subcortical structures,
white matter areas, and cortical thickness values, we
compared the clusters with the goal of identifying the
specific localization of lesions. For this comparison, we
used the Kolmogorov-Smirnov test to analyze the normality
(4)
(5)
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of the samples and the two-tailed t-test for independent
samples.
Characterization of neuropsychological indexes
Healthy individuals were submitted to the neuropsycho-
logical evaluation using the Mattis Dementia Rating Scale
(MDRS) (20), Stroop Test (21,22), Verbal Fluency test (23),
Wisconsin Card Sorting Test (WCST) (24), Rey Complex
Figure test (25), Vocabulary – Wais – III (26), Logical
Memory (WMS-R) test (27), Visual Reproduction (WMS-R)
(27) and Rey Auditory-Verbal Learning Test (RAVLT) (28),
conducted by a neuropsychologist with experience in
cognitive assessment of elderly individuals. Other demo-
graphic variables were collected by informal questionnaires
with the patient such as schooling, occupation, socio-
economic level and handedness.
Data analysis
The performance of each participant during the neurop-
sychological evaluation was standardized in z-scores
according to the mean and standard deviation of this study
group and the signs were inverted for the measures for
which a higher score indicated a poorer performance, as
was the case for the measures of processing time.
These neuropsychological results were divided according
to the quantitative MRI measures, and a comparison
between the groups was performed by the Mann-Whitney
nonparametric test of the SPSS 13.0 for Windows including
the variables age and schooling.
& RESULTS
The cluster analysis identified one group in which the
brain MRI markers were more preserved and another in
which the brain MRIs showed less preserved markers. The
cluster 1 had the best results with respect to quantitative
MRI measures (high volumes and MTRs) and cluster 2 had
the worst results (low volumes and MTR values and high
T2 values). With regard to volume, cluster 1 had higher
significant values than the second cluster at global (brain
parenchyma fraction (p= 0.02) and local levels (left brain
white matter (p= 0.02), left cerebral cortex (p= 0.03), right
brain white matter (p= 0.004), and right cerebral cortex
(p=0.02)) (Figure 1). The cortical regions had a greater
number of distinct regions compared with WM and
subcortical structures. There was also an increased involve-
ment of the left cerebral cortex compared with the right
cerebral cortex, for both gray and white matter. The frontal
and temporal lobes were more affected than the other
regions in the two groups.
The MTR showed predominant changes in WM and
subcortical structures, with more conserved values in
cluster 1 (p,0.05) (Figure 1). The qT2 showed more
extensive abnormalities than MTR, especially in the right
cerebral cortex (Figure 1). The MTR and qT2 demonstrated
more preserved indices for cluster 1 in the pars triangularis,
medial temporal regions (including entorhinal regions), the
pre-motor frontal lobe of the left cerebral cortex, and the
right cortical regions of the frontal lobe. Volume analysis of
subcortical structures revealed more preserved values for
cluster 1 in the hippocampus, amygdala, and ventral
diencephalon bilaterally, as well as in the left thalamus,
brain stem, left accumbens area, and right cerebellum. The
middle posterior corpus callosum, anterior middle corpus
callosum, and central corpus callosum (Figure 1) also
demonstrated differences between groups. The differences
in magnetization transfer between the clusters were
significant in the left ventral diencephalon, optic chiasm,
mid-anterior corpus callosum, and bilaterally in the
amygdale. The qT2 revealed better indices for cluster 1 in
the left thalamus proper, left and right hippocampus, and
central corpus callosum.
The participants in cluster 1 had a mean age of 66.4¡5.2
years and 7.3¡4.2 years of schooling, while those in cluster
2 had a mean age of 75.4¡4.8 years and 7.8¡5.2 years of
schooling. Occupations varied in clusters 1 and 2, with half
of the participants being retired (51-54%), 26-18% being
housewives, and 22-27% being employed. The right-hand
preference was prevalent for clusters 1 and 2. In both
clusters, 55-54% of the participants were of low socio-
economic status, while 44-45% were of middle socio-
economic status. There were no significant differences
(p,0.05) between the clusters with regard to education,
occupation, handedness, and socioeconomic level, but
significant differences in age were found.
Due to the differences in neuropsychological performance
between cluster 1 (mean age of 66.4 years) and cluster 2
(mean age of 75.4 years), we encountered significant
differences in the interference indices of the Stroop test
(p= 0.024) (Figure 2). In addition, cluster 1 had better
weighted scores (z-score: +0.142) than cluster 2 (z-score: -
0.650). There were also significant differences in age
between the clusters (p,0.0001, Figure 3), whereas no
significant difference was noted in years of schooling
(p= 0.536). Therefore, the older group, which had worse
indices of interference in the Stroop test, also had inferior
results in MRI than the younger group.
& DISCUSSION
Controversy remains regarding the relationship between
brain volumes and cognition in healthy elderly, yet changes
in the aging brain structure are shown by MRI and described
as an increase in size of the cerebral ventricles and reduction
in volume of the cerebral cortex, hippocampus, and
parahippocampal gyrus related to aging (29). However,
cognitive declines in aging involve mechanisms other than
those that are purely structural, such as alterations in the
production of neurotransmitters (dopaminergic explanation),
dysfunction of some cognitive domains (inhibitory control
hypothesis, hypothesis of slow mental processing, and
frontal hypothesis), and sensory losses, among others.
These theories are not mutually exclusive, and a theory that
unifies and explains the interrelatedmechanisms of cognitive
aging in these different levels is still missing (1).
Previous studies in this area seem to consider only one
side of the equation between brain and behavior, without
explaining their relationships; therefore, the present study
is important because it compared MRI results with
neuropsychological performance in two groups of healthy
elderly, one in the sixth decade of life and another in the
seventh decade of life. This study began with the analyses of
biological markers associated with MRI findings in two
clusters, namely cluster 1 (mean 66.4 years), consisting of
participants who had less volumetric change in MTR and
qT2, and cluster 2 (mean 75.4 years), consisting of
participants who had global atrophy, a low MTR, and a
prolonged T2 time. Such findings are in accordance with
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studies that indicate a more rapid decline in cognition after
70 years of age (8,9). These results did not show differences
with respect to other variables such as educational level,
occupation, socioeconomic level, and handedness, which
could explain such discrepancies.
The MRI results showed that cortical regions were more
affected than white matter and subcortical structures in the
older cluster. Other studies demonstrated that cortical gray
matter atrophy predicted cognitive decline regardless of
whether lacunes were present; neither lacunes nor white
matter hyperintensity independently predicted decline (30).
Although many histological studies have demonstrated that
white matter changes are more prominent than cortical
changes with aging (31-37), other authors indicated a
greater loss of gray matter in mild cognitive impairment
(MCI), with a greater risk of conversion to dementia than in
stable MCI (38). Another study using a cross-sectional,
population-based VBM also revealed an accelerated gray
matter loss exclusively in men, involving the temporal
neocortex, prefrontal neocortex, and medial temporal
regions (39). Even though our study included more women
than men, it did not reveal differences related to gender.
Figure 1 - Brain Volumetric Changes.
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Subcortical structures were less affected by age than
cortical structures, but significant differences (p,0.05) were
found in the volume of the left thalamus proper, brain stem,
left acumens area, and right cerebellum white matter, as well
as bilaterally in the hippocampus, amygdale, and ventral
diencephalon. These findings are comparable to those of
other studies indicating that the greatest shrinkage across the
lifespan occurs in the caudate, cerebellum, hippocampus,
Figure 2 - Stroop test (z-scores) and MRI.
Figure 3 - Relationship between Age and RMI.
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and prefrontal areas (6). Previous studies also argued that
subcortical structures, such as the striatum, have not been
extensively studied in aging, and similarly little is known
about changes in the volume of the cerebellum (5,40,41).
According to the present study, the subcortical structures do
not seem to change significantly with age, as we verified
more involvement of the cortical regions.
The MTR provides an indication of the quantity of
protons bound to macromolecules in a given tissue, and
our study revealed WM impairment in addition to volume
loss. The MTR is reduced in many pathological processes,
particularly those associated with demyelination and axonal
damage (42). Decreases in the MTR have been reported in
experimental models of Wallerian degeneration after optic
nerve lesions (43).
Clinical studies have reported that MTR measurements
show major reductions in processes related to demyelina-
tion, axonal loss, and tissue destruction (44). The MTR has
been extensively used for the assessment of central nervous
systemWM lesions in different diseases, especially in MS, in
which the MTR is used to predict disease progression (45-
48). Although brain atrophy may be associated with the
MTR decrease, pathological correlations have demonstrated
that the main cause of the MTR decrease is demyelination.
In addition, in normal-appearing WM, the MTR decrease
correlates with axonal attenuation. Therefore, we speculate
that the MTR decrease in our cohort may be explained by a
combination of neuronal and axonal damage and demyeli-
nation related to aging.
The qT2 showed abnormalities in cortical structures
related to the right cerebral cortex, as well as the MTR.
Both of these MRI metrics revealed changes in cortical
structures that were most severe in the second cluster in the
left cortex associated with the temporal-frontal cortex and
right cerebral cortex of the frontal lobe.
Therefore, our data demonstrated that the frontal and
temporal lobes were preferentially affected (Figure 1). Many
studies also concluded that the prefrontal cortices were the
most affected by aging compared with other neocortical
regions, followed by losses in parietal, temporal, and
occipital cortices (1,5,8).
As already cited, the cortical areas were more affected
than the other areas, and the relationship between gray
matter loss and executive functions probably indicates
processes that affect the frontal cortex by direct neuronal
loss, loss of neocortical association ascending pathways, or
damage to fronto-subcortical circuits (49). Executive func-
tioning was impaired with the increase in white matter
hyperintensities and the loss in volume of the prefrontal
cortex (50). The analysis of the MTR in this study indicated
lower values in the anterior regions of the brain in cluster 2,
suggesting that this group of older elderly individuals with
less preserved brain volume and worse neuropsychological
scores possesses smaller areas of myelination than cluster 1.
Thus, decreased myelination of nerve fibers appears to
influence the biological and neuropsychological measures of
aging (inhibitory control) even in a healthy aging group.
The decrease in MTR and the increase in relaxation time
of the brain MRI is a sign of healthy tissue loss that may be
observed more in the left cerebral hemisphere, mainly in the
temporal and frontal areas, whereas these occurrences were
confined to the frontal lobe in the right hemisphere cortical
areas. This finding suggests greater tissue integrity loss in
anterior areas of the brain, especially in the frontal cortex.
The vulnerability of the frontal lobes to cognitive aging is
the basis of one of the most accepted theories of cognitive
aging known as the Frontal Lobe Hypothesis of Aging. This
hypothesis postulates that the decline in frontal efficiency
can account for many of the cognitive deficits associated
with cognitive aging, such as impared executive functions
(1).
The Stroop test, Color and Trail-Making Test, Word
Fluency tests, and Wisconsin Card Sorting Test (WCST)
were administered to evaluate executive functions. The
Stroop test (interference index) was the only test that
indicated differences between clusters 1 and 2, with worse
MRI measures found in the older elderly (cluster 2)
compared with the younger elderly cluster (cluster 1). The
effect of age on the Stroop interference paradigm could be
attributable to the slowness in mental processing time;
however, this slowness would lead to a decrease in the
reading speed for incongruent words, leading to the Stroop
interference effect (41). In the current study, the rate of
interference was measured by dividing the time (in seconds)
necessary to name colored dots by the time required to
name the colors of words written with the names of
different colors.
Changes in inhibitory control constitute one of the
hypotheses about cognitive aging that may relate it to a
healthy process of human development. However, other
authors pointed out that errors in the color incongruent trials,
in a computerized version of the Stroop test, along with
differences between congruent and incongruent trials (inter-
ference index), were the strongest predictors of conversion to
Alzheimer’s disease (AD) (51). Accordingly, deficits in the
Stroop test could be an incipient symptom of the develop-
ment of pathological states that are not exclusively related to
cognitive aging and deserve other follow-up.
According to our results, signs of neuronal loss were
more frequent in the frontal lobe in both clusters but could
also be observed in the left temporal lobe. Other authors
showed greater gray matter loss in the hippocampus and
hippocampal structures and less loss in the posterior
cingulate cortex, inferior temporal gyrus and middle fusi-
form gyrus, precuneus, tempoparietal junction, and frontal
cortex in the pre-clinical stages of dementia, which diverges
from the results in our study group and seems to place them
at a higher risk for dementia (38).
In general, different authors have linked memory decline
with hippocampal volume loss in elderly individuals
(5,30,40,49,50). However, our results did not reveal such a
correlation, probably because this series was restricted to
healthy elderly participants, whichmay not be representative
of the normal aging group as a whole. Moreover, it was not
possible to compare these results with population normative
data that could explain the lack of significant differences
between groups in measures of memory. Indeed, it must be
considered that the assessment of cognitive decline was
beyond the scope of this work because it was not a
longitudinal study.
In conclusion, our data allow the inference that the
heterogeneity of normal aging can be expressed functionally
and structurally, which may explain the overlap between
normal and pathological groups in studies comparing mild
cognitive impairment and early dementia. From a functional
point of view, these results are in accordancewith the inhibitory
control hypotheses regarding cognitive aging. Investigations of
the normal spectrum of aging are essential for the study of the
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pre-clinical stages of all degenerative processes associatedwith
aging and can highlight some biological and neuropsycholo-
gical markers of incipient cases of dementia.
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